文献速递慢性肾脏病血液净化与透析

外周动脉疾病:伴与不伴CKD的不良后果

Peripheral Artery Disease: Its Adverse Consequences With and Without CKD.
PubMed 文献 · Am J Kidney Dis · 2019-12-23

该回顾性队列研究纳入453573名马尼托巴省成人,发现PAD患病率为4.5%。在eGFR≥60、CKD G3-G5及透析患者中,PAD均与全因死亡、心血管事件和下肢并发症风险升高相关;CKD G5D患者下肢并发症风险较eGFR≥60且无PAD者高10-12倍。

要点

  • PAD在CKD G3-G5和G5D患者中更常见,且常导致下肢并发症。
  • CKD G5D患者下肢并发症事件率高达75/1000患者年。
  • 需针对CKD人群设计医疗干预和护理路径以预防下肢并发症。

核心结论

  • PAD在CKD G3-G5和G5D患者中比eGFR≥60者更常见,并频繁导致下肢并发症。

研究设计与样本

  • 回顾性队列研究,纳入2007-2014年间马尼托巴省453573名至少有一次血清肌酐测量的成人居民。

主要发现

  • 研究人群PAD患病率为4.5%,PAD患者年龄更大、男性更多、合并糖尿病和CKD等疾病负担更高。
  • PAD与eGFR≥60、CKD G3-G5及透析患者全因死亡、心血管事件和下肢并发症风险升高相关。
  • CKD人群PAD的风险比虽较低,但事件率更高;CKD G5D无PAD和有PAD者下肢并发症调整HR分别为10.36(95%CI 8.83-12.16)和12.02(95%CI 9.58-15.08),事件率75/1000患者年。

临床怎么用

  • 在CKD G3-G5和G5D患者中应警惕PAD及下肢并发症风险,考虑针对性筛查与干预。

局限性

  • 使用行政编码可能低估PAD和并发症,且难以评估PAD医疗质量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVES: Chronic kidney disease (CKD) is a potent risk factor for macrovascular disease and death. Peripheral artery disease (PAD) is more common in patients with CKD and is associated with lower-limb complications and mortality. We sought to compare the prevalence of PAD in and outside the setting of kidney disease and examine how PAD affects the risk for adverse health outcomes, specifically lower-limb complications, cardiovascular events, and survival. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 453,573 adult residents of Manitoba with at least 1 serum creatinine measurement between 2007 and 2014. EXPOSURE: PAD defined by hospital discharge diagnosis codes and medical claims. OUTCOMES: All-cause mortality, cardiovascular events, and lower-limb complications, including foot ulcers and nontraumatic amputations. ANALYTICAL APPROACH: Survival analysis using Cox proportional hazards models. RESULTS: The prevalence of PAD in our study population was 4.5%, and patients with PAD were older, were more likely to be male, and had a higher burden of comorbid conditions, including diabetes and CKD. PAD was associated with higher risks for all-cause mortality, cardiovascular events, and lower-limb complications in patients with estimated glomerular filtration rate (eGFR) ≥ 60mL/min/1.73m2, those with CKD GFR categories 3 to 5 (G3-G5), and those treated by dialysis (CKD G5D). Although HRs for PAD were lower in the CKD population, event rates were higher as compared with those with eGFR≥60mL/min/1.73m2. In particular, compared with patients with eGFR≥60mL/min/1.73m2 and without PAD, patients with CKD G5D had 10- and 12-fold higher risks for lower-limb complications, respectively (adjusted HRs of 10.36 [95% CI, 8.83-12.16] and 12.02 [95% CI, 9.58-15.08] for those without and with PAD, respectively), and an event rate of 75/1,000 patient-years. LIMITATIONS: Potential undercounting of PAD and complications using administrative codes and the limited ability to examine quality-of-care indicators for PAD. CONCLUSIONS: PAD is more common in patients with CKD G3-G5 and G5D compared with those with eGFR≥60mL/min/1.73m2 and frequently leads to lower-limb complications. Medical interventions and care pathways specifically designed to slow or prevent the development of lower-limb complications in this population are urgently needed.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Bourrier M, Ferguson TW, Embil JM, et al. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD. Am J Kidney Dis. 2019. PMID: 31879218. doi:10.1053/j.ajkd.2019.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。